Investigators assessed a large population of Italian patients with resistant multiple sclerosis spasticity treated with THC:CBD to determine real-life, long-term efficacy outcomes. PHILADELPHIA — Real ...

A combination of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) relieved certain neurophysiological symptoms affecting patients with secondary progressive multiple sclerosis (MS). Oral spray ...

Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs. Oral spray containing two compounds ...

BOSTON — A new study finds measurable benefit on lower-limb spasticity in patients with progressive multiple sclerosis (MS) with a tetrahydrocannabinol-cannabidiol (THC-CBD) oromucosal spray (Sativex, ...

Cannabis compounds given through oral spray decreased spasticity more when compared to the placebo in patients already taking anti-spasticity drugs for motor neuron disease. Chemical compounds derived ...

CBD (cannabidiol) and THC (tetrahydrocannabinol) are two of the most well-known compounds found in the cannabis plant. While they share a common origin, their effects on the human body are quite ...

Porton Down, UK, 2 March 2011: GW Pharmaceuticals (AIM: GWP) announces that positive results from a Phase III clinical study of Sativex® Oromucosal Spray (delta-9-tetrahydrocannabinol (THC) and ...

Per the authors, at the time of manuscript writing, 30 states and the District of Columbia had passed laws legalizing cannabis in some form, with 9 states allowing the recreational use of cannabis.

Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs. Chemical compounds derived from the ...